MarketInOut Stock Screener Log In | Sign Up

Chongqing Lummy Pharmaceutical Co Ltd

SZSE • Healthcare • Drug Manufacturers - General • Quote as of 10/28/2026 13:35
Chongqing Lummy Pharmaceutical Co Ltd stock price and volume chart

Company Profile

IndustryDrug Manufacturers - General
SectorHealthcare
ExchangeSZSE
Market Capitalization6,926.78 mln
Float889 mln

Piotroski F-Score

4 / 9
Borderline

Beneish M-Score

-2.86
Likely reliable

Relative Strength

99 / 100
Top performer

Debt / Equity

0.30
Low leverage

Pre-Tax Margin

-16%
Loss-making

ROE

-5.74
Negative

Business Description

Founded in 1999 and based in Chongqing, China, Lummy Pharmaceutical researches, makes, and sells a wide range of medicines across the country. Its products cover many areas of healthcare, including cancer treatment, heart health, infection control, digestion, and hormone-related conditions, among others.

Key Fundamentals

EPS-0.12
ROE-5.74
RPS0.71
ROIC-7.39
ROA-3.83
Interest Cover-12.45
EBITDA, mln-51.88
EV / EBITDA-102
EV / EBIT-51.32
Revenue, mln746
EV / Revenue7.13

Quote Details

Last 9.92
Change 1.65 (19.95%)
Open 8.43
Volume 257,027,920
Turnover 2,549,716,992
Average Volume 164,490,800

Financial Ratios

Pre-Tax Profit Margin-16
Leverage Ratio1.58
Current Ratio1.99
Price / Book3.36
Price / Tangible Book3.89
Price / Cash Flow83.35
Price / Free Cash Flow111
Debt / Equity0.30
Price / Sales7.88

Financial Strength

Altman Z-Score3.68
Piotroski F-Score 4 / 9
Beneish M-Score-2.86
Price to Intrinsic Value2.78

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 6.67% 94 / 100   
1 Month 80.04% 100 / 100   
2 Months 98% 100 / 100   
6 Months 54.04% 99 / 100   
1 Year 130% 99 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Blog